Tech Company Financing Transactions
Solazyme Funding Round
Solazyme, based in South San Francisco, scored $52 million from Morgan Stanley Expansion Capital, Braemar Energy Ventures and Chevron Technology Ventures.
Transaction Overview
Company Name
Announced On
8/9/2010
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series D
Investors
Proceeds Purpose
Proceeds purpose were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Alternative Energy
Mailing Address
225 Gateway Blvd.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Solazyme (NASDAQ: SZYM) is a biotechnology company devoted to harnessing the energy-harvesting machinery of photosynthetic microbes to produce valuable products. The Company utilizes proprietary genetic engineering methods to develop commercially relevant, sunlight-driven biochemical pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Wolfson
Chief Financial Officer
Tyler Painter
Executive Vice President
Peter Licari
General Manager
Frederic Stoeckel
VP - General Counsel
Paul Quinlan
Browse more venture capital transactions:
Prev: 8/9/2010: My Damn Channel venture capital transaction
Next: 8/9/2010: CRE Secure venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs